Thomas Trimarchi - 21 Aug 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
President and CFO
Signature
/s/ Damian Wilmot, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
21 Aug 2025
Transactions value $
-$2,090,081
Form type
4
Filing time
22 Aug 2025, 16:58:52
Previous filing
19 Aug 2025
Next filing
18 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Trimarchi Thomas President and CFO C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO /s/ Damian Wilmot, Attorney-in-Fact 22 Aug 2025 0002030813

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Sale -$2.09M -42.2K -9.12% $49.48 421K 21 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sale price of the shares sold from $49.08 to $49.77 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.